Calcium Channel Blocker-Related Chylous Ascites: A Systematic Review and Meta-Analysis


Tsai Meng-Ko,Lai Chao-Hung,Chen Li-Mien,Jong Gwo-PingORCID


Background: Chylous ascites is an uncommon condition characterized by a white, milky-appearing peritoneal fluid, and is related to disruption of the lymphatic system from any cause. There have been very few previous reports of calcium channel blockers (CCBs) as potential causes of chylous ascites, and most of the patients were undergoing peritoneal dialysis. Aims: To review the pathogenesis, clinical manifestations, laboratory examinations, treatment options, and prognosis of patients with CCB-related chylous ascites. Method: A retrospective analysis was conducted for patients with CCB-related chylous ascites from publications in PubMed, EMBASE, and LILACS between January 1993 and December 2018. Results: A total of 48 cases were included. The average age at disease onset was 50.2 ± 10.9 years, with a male:female ratio of 1.5:1.0. The symptoms of abdominal distension/pain and chylous ascites were observed within 48–72 h of drug initiation and disappeared within 24 h of drug withdrawal. Rechallenge was performed in 10 patients, and all (100%) of them showed chylous effluents that disappeared within 24 h after stopping drug treatment. Conclusions: To summarize, CCB-related chylous ascites is formed of white, milky ascites/effluents that appear after administration of CCBs. Physicians must be aware of the possibility of chylous ascites when administering CCBs, particularly in patients with renal function impairment or patients with end-stage renal disease who are undergoing peritoneal dialysis.




General Medicine

Reference26 articles.

1. Chylous ascites: Diagnosis, causes and treatment;Laterre;Acta Gastroenterol. Belg.,2002

2. Lercanidipine-induced chylous ascites: Case report and literature review

3. Amlodipine induced chylous ascites in a patient undergoing peritoneal dialysis;Gupta;Ann. Appl. Bio-Sci.,2016

4. A drug-induced turbid peritoneal dialysate in five patients treated with continuous ambulatory peritoneal dialysis;Yoshimoto;Clin. Nephrol.,1993

5. Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis;Yoshimoto;Clin. Nephrol.,1998

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献







Copyright © 2019-2021 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3